CD44 and chronic myelogenous leukemia, BCR-ABL1 positive: Inhibition of the interaction of CD44 with E-selectin by GMI-1271, an E-selectin inhibitor, in combination with imatinib led to greater elimination of LSCs in a murine model of CML.